Daniel Tarsy, M.D.

Concepts (440)

Back to Profile

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name	Number of Publications	Most Recent Publication	Publications by All Authors	Concept Score	Why?
Deep Brain Stimulation	14	2014	851	1.860	Why?
Parkinson Disease	34	2016	2893	1.780	Why?
Dyskinesia, Drug-Induced	20	2012	165	1.710	Why?
Botulinum Toxins	13	2016	191	1.400	Why?
Dystonia	12	2012	378	1.300	Why?
Subthalamic Nucleus	8	2014	203	1.060	Why?
Botulinum Toxins, Type A	6	2013	238	0.870	Why?
Essential Tremor	5	2013	161	0.820	Why?
Tremor	7	2013	197	0.820	Why?
Torticollis	7	2010	69	0.770	Why?
Parkinsonian Disorders	4	2016	285	0.710	Why?
Dyskinesias	3	2011	79	0.690	Why?
Antipsychotic Agents	15	2011	3081	0.660	Why?
Dystonic Disorders	8	2011	354	0.590	Why?
Movement Disorders	10	2016	463	0.590	Why?
Metoclopramide	6	2007	51	0.590	Why?
Levodopa	16	2012	221	0.550	Why?
Anti-Dyskinesia Agents	4	2001	24	0.550	Why?
Ventral Thalamic Nuclei	2	2013	43	0.490	Why?
Dopamine Antagonists	4	2007	284	0.460	Why?
Voice Disorders	2	2012	286	0.450	Why?
Sneezing	1	2013	16	0.440	Why?
Gait Disorders, Neurologic	3	2012	243	0.440	Why?
Injections, Intraocular	1	2013	36	0.430	Why?
Blepharospasm	1	2013	34	0.420	Why?
Apoptosis Regulatory Proteins	7	2011	1151	0.410	Why?
Antiparkinson Agents	7	2011	184	0.410	Why?
Antiparasitic Agents	1	2012	42	0.400	Why?
Voice Training	1	2012	44	0.380	Why?
Reflex	1	2013	375	0.370	Why?
Meige Syndrome	2	2001	12	0.370	Why?
Anticonvulsants	3	2008	1923	0.360	Why?
Speech Disorders	1	2012	179	0.360	Why?
Needles	1	2013	461	0.340	Why?
Neuromuscular Agents	3	2006	148	0.340	Why?
Dopamine	15	2009	1592	0.320	Why?
Psychotherapy, Group	1	2012	417	0.300	Why?
Basal Ganglia Diseases	4	2002	145	0.290	Why?
Dopamine Agents	1	2008	188	0.290	Why?
Akathisia, Drug-Induced	2	2006	66	0.280	Why?
Masticatory Muscles	1	2006	31	0.260	Why?
Fructose	1	2008	284	0.260	Why?
Thalamus	3	2013	1047	0.250	Why?
Piracetam	1	2006	88	0.250	Why?
Quinolones	1	2009	389	0.250	Why?
Jaw Diseases	1	2006	91	0.250	Why?
Gastroparesis	1	2007	143	0.240	Why?
Ulnar Neuropathies	1	2004	32	0.220	Why?
Globus Pallidus	4	2012	248	0.220	Why?
Stiff-Person Syndrome	2	2013	31	0.220	Why?
Spasm	1	2004	131	0.220	Why?
Nuclear Proteins	7	2011	5804	0.220	Why?
Dysarthria	1	2003	56	0.220	Why?
Neurology	1	2011	786	0.210	Why?
Extrapyramidal Tracts	1	2002	17	0.200	Why?
Multiple System Atrophy	1	2003	132	0.190	Why?
Acetamides	2	2001	259	0.190	Why?
Gait	3	2016	823	0.190	Why?
Carbidopa	4	2012	30	0.190	Why?
Polyradiculoneuropathy	1	2001	65	0.180	Why?
DNA-Binding Proteins	7	2011	9615	0.180	Why?
Diabetes Complications	1	2007	1320	0.180	Why?
Humans	115	2016	768166	0.170	Why?
Middle Aged	54	2016	223492	0.160	Why?
Injections, Intramuscular	4	2006	556	0.160	Why?
Verbal Behavior	2	2014	336	0.160	Why?
Severity of Illness Index	11	2016	15948	0.160	Why?
Whiplash Injuries	1	1998	15	0.150	Why?
Piperazines	1	2009	2554	0.150	Why?
Neurologic Examination	3	2006	914	0.150	Why?
Neurosurgical Procedures	1	2009	2076	0.150	Why?
Neck Pain	1	1999	191	0.150	Why?
Myasthenia Gravis	1	2000	215	0.140	Why?
Aged	37	2016	171504	0.140	Why?
Deglutition Disorders	1	2003	640	0.140	Why?
Electric Stimulation Therapy	1	2003	635	0.140	Why?
Gastrointestinal Agents	1	2002	511	0.140	Why?
Neuroleptic Malignant Syndrome	2	1996	74	0.140	Why?
Haloperidol	5	1996	394	0.140	Why?
Nortropanes	1	2016	12	0.140	Why?
Attitude of Health Personnel	1	2011	3929	0.140	Why?
Monitoring, Ambulatory	2	2010	358	0.140	Why?
Sialorrhea	1	2016	25	0.140	Why?
Brachial Plexus	1	1997	171	0.130	Why?
Occupational Diseases	1	2004	1457	0.130	Why?
Cervical Vertebrae	2	2001	979	0.130	Why?
Serotonin Antagonists	1	1996	147	0.120	Why?
Muscle Spasticity	1	1996	159	0.120	Why?
Male	62	2016	364719	0.120	Why?
Bartonella henselae	1	1995	15	0.120	Why?
Cat-Scratch Disease	1	1995	23	0.120	Why?
Motor Activity	8	2014	2711	0.120	Why?
Spinal Injuries	1	1998	300	0.120	Why?
Tourette Syndrome	2	1996	400	0.120	Why?
Epilepsies, Myoclonic	1	1995	85	0.120	Why?
Female	49	2016	397192	0.120	Why?
Treatment Outcome	16	2016	65371	0.110	Why?
Electric Injuries	1	1994	24	0.110	Why?
Intracranial Embolism and Thrombosis	1	1993	144	0.110	Why?
Risperidone	1	1996	383	0.110	Why?
Receptors, Dopamine	5	1984	293	0.110	Why?
Functional Laterality	6	2012	2264	0.110	Why?
Adult	40	2016	223646	0.110	Why?
Neuroprotective Agents	1	2000	958	0.110	Why?
Risk	5	2009	9613	0.110	Why?
Physicians	1	2011	4598	0.100	Why?
Dystonia Musculorum Deformans	5	2010	158	0.100	Why?
Amantadine	3	2012	59	0.100	Why?
Subthalamus	1	2012	4	0.100	Why?
Physical Therapy Modalities	2	2006	533	0.100	Why?
Quality of Life	4	2013	13490	0.100	Why?
Catechols	1	2012	63	0.100	Why?
Leg Injuries	1	1994	180	0.100	Why?
Drug Resistance	2	2009	1599	0.100	Why?
Speech Therapy	1	2012	58	0.100	Why?
Coma	2	1995	485	0.100	Why?
Mutation, Missense	7	2010	2592	0.090	Why?
Codon	5	2010	599	0.090	Why?
Outpatient Clinics, Hospital	1	2013	392	0.090	Why?
Tomography, Emission-Computed, Single-Photon	1	2016	1140	0.090	Why?
Epilepsies, Partial	1	1995	435	0.090	Why?
Hand Injuries	1	1994	239	0.090	Why?
Carotid Artery, Internal	1	1993	440	0.090	Why?
Facial Injuries	1	2012	191	0.090	Why?
Antibodies, Monoclonal, Murine-Derived	1	2013	696	0.090	Why?
Physostigmine	5	1978	50	0.090	Why?
Aged, 80 and over	13	2016	59629	0.090	Why?
Receptors, N-Methyl-D-Aspartate	2	2009	903	0.080	Why?
Time Factors	10	2013	40218	0.080	Why?
Mobility Limitation	1	2013	409	0.080	Why?
Drug Evaluation	3	2008	642	0.080	Why?
Diagnosis, Differential	6	2016	13014	0.080	Why?
Capsaicin	1	1990	235	0.080	Why?
Somatoform Disorders	1	2012	425	0.080	Why?
Reserpine	5	1975	63	0.080	Why?
Patient Selection	2	2004	4260	0.080	Why?
Status Epilepticus	1	1995	463	0.080	Why?
Aortic Valve Insufficiency	1	1993	577	0.080	Why?
Task Performance and Analysis	1	2013	771	0.080	Why?
Acceleration	1	2010	189	0.080	Why?
Computer Communication Networks	1	2010	295	0.080	Why?
Amino Acid Substitution	5	2010	1743	0.080	Why?
Behavior, Animal	6	1977	1862	0.080	Why?
Exercise Test	1	2016	2186	0.080	Why?
Telemetry	1	2010	200	0.080	Why?
Aphasia	1	2010	193	0.080	Why?
Brain Abscess	1	2009	123	0.080	Why?
Substantia Nigra	5	1978	346	0.080	Why?
Microelectrodes	2	2014	305	0.080	Why?
Face	2	2012	1029	0.070	Why?
Sodium-Potassium-Exchanging ATPase	1	2010	480	0.070	Why?
Picrotoxin	3	1978	61	0.070	Why?
Apomorphine	6	1978	148	0.070	Why?
Cyclophosphamide	1	2013	2227	0.070	Why?
Dihydroxyphenylalanine	4	1977	74	0.070	Why?
Deanol	2	1977	2	0.070	Why?
Nitriles	1	2012	980	0.070	Why?
Cross-Over Studies	2	2016	2107	0.070	Why?
Neck Muscles	2	1997	100	0.070	Why?
Diabetic Neuropathies	1	1990	410	0.070	Why?
Muscle Rigidity	2	2006	41	0.070	Why?
Radiopharmaceuticals	1	2016	2735	0.070	Why?
Hypokinesia	1	2006	23	0.070	Why?
Multicenter Studies as Topic	3	2007	1737	0.070	Why?
Electrodes, Implanted	3	2014	836	0.070	Why?
Lasers	1	2010	952	0.070	Why?
Myoclonus	2	1978	107	0.060	Why?
Movement	1	2013	1490	0.060	Why?
Ethanolamines	2	1977	152	0.060	Why?
Molecular Structure	1	2010	1883	0.060	Why?
Cerebellum	1	2013	1522	0.060	Why?
Affect	1	2013	1495	0.060	Why?
Huntington Disease	4	2000	1147	0.060	Why?
Cues	1	2010	878	0.060	Why?
Cholinergic Antagonists	1	2006	167	0.060	Why?
Caudate Nucleus	2	1978	391	0.060	Why?
Base Sequence	6	2011	12421	0.060	Why?
Calcinosis	1	1993	1481	0.060	Why?
Tranquilizing Agents	5	1977	60	0.060	Why?
Combined Modality Therapy	2	2009	8542	0.060	Why?
Epilepsy	1	2000	3327	0.060	Why?
Motor Skills	2	2006	523	0.060	Why?
Molecular Chaperones	1	2009	762	0.060	Why?
Disease Progression	3	2012	13671	0.060	Why?
Double-Blind Method	7	2016	12465	0.060	Why?
Monoamine Oxidase Inhibitors	1	2004	153	0.060	Why?
Corpus Striatum	8	1978	1224	0.060	Why?
Immunologic Factors	1	2013	1596	0.060	Why?
Indans	1	2004	92	0.060	Why?
Photic Stimulation	1	2010	1997	0.060	Why?
Aortic Valve	1	1993	1970	0.050	Why?
NADH Dehydrogenase	1	2003	47	0.050	Why?
Parkinson Disease, Secondary	5	1984	120	0.050	Why?
Putamen	1	2003	291	0.050	Why?
Pons	1	2003	242	0.050	Why?
Pimozide	4	1975	21	0.050	Why?
Data Collection	1	2011	3327	0.050	Why?
Internet	2	2010	3110	0.050	Why?
Accidental Falls	1	2009	1080	0.050	Why?
Chlorpromazine	4	1975	111	0.050	Why?
Retrospective Studies	7	2014	81762	0.050	Why?
Electromyography	1	2006	1401	0.040	Why?
Piperidines	1	2009	1667	0.040	Why?
Pilot Projects	2	2012	8741	0.040	Why?
Survival Analysis	1	2013	10101	0.040	Why?
Follow-Up Studies	7	2012	39348	0.040	Why?
Muscle Tonus	2	1997	82	0.040	Why?
Time Perception	1	2001	87	0.040	Why?
Phenethylamines	1	2000	95	0.040	Why?
Clothing	2	2010	96	0.040	Why?
Dose-Response Relationship, Drug	10	2004	10760	0.040	Why?
Muscle, Skeletal	2	2010	4978	0.040	Why?
Pain Measurement	3	1999	3583	0.040	Why?
Parasympatholytics	2	1984	89	0.040	Why?
Rotation	3	1975	517	0.040	Why?
Stereotyped Behavior	5	1978	133	0.040	Why?
Long-Term Care	2	2000	631	0.040	Why?
Hand	1	2004	913	0.040	Why?
Decision Making	1	2012	3953	0.040	Why?
Receptors, Drug	2	1975	157	0.040	Why?
Atrophy	1	2003	1646	0.040	Why?
Trifluoperazine	1	1977	40	0.040	Why?
Substance Withdrawal Syndrome	2	1983	628	0.040	Why?
Hepatolenticular Degeneration	1	1978	73	0.040	Why?
Somatosensory Cortex	1	2002	516	0.040	Why?
DNA, Mitochondrial	1	2003	872	0.040	Why?
Excitatory Amino Acid Antagonists	1	2000	451	0.040	Why?
Space Perception	1	2001	466	0.040	Why?
Mutation	3	2011	30238	0.040	Why?
Injections	2	1997	840	0.040	Why?
Catecholamines	2	1976	389	0.040	Why?
Clinical Trials as Topic	6	2007	8054	0.030	Why?
Pyrimidines	1	2009	3048	0.030	Why?
Brain	8	2016	27360	0.030	Why?
Analysis of Variance	2	2016	6229	0.030	Why?
Basal Ganglia	4	1980	553	0.030	Why?
Software	1	2010	4478	0.030	Why?
Parotid Gland	1	2016	178	0.030	Why?
Palliative Care	1	1990	3643	0.030	Why?
Mesencephalon	1	1977	338	0.030	Why?
Norepinephrine	2	1975	898	0.030	Why?
Acute Disease	3	1998	7243	0.030	Why?
Genetic Variation	1	2010	6611	0.030	Why?
Adolescent	8	2011	89169	0.030	Why?
Mental Disorders	2	2011	6874	0.030	Why?
gamma-Aminobutyric Acid	2	1978	1141	0.030	Why?
Clonidine	1	1975	170	0.030	Why?
Reflex Sympathetic Dystrophy	1	1994	60	0.030	Why?
User-Computer Interface	2	2010	1407	0.030	Why?
Chorea	1	1974	80	0.030	Why?
Parasympathomimetics	1	1972	28	0.030	Why?
Intraoperative Complications	1	2000	1171	0.030	Why?
Sympatholytics	1	1972	82	0.030	Why?
Idoxuridine	1	1973	111	0.030	Why?
Sympathomimetics	1	1972	57	0.030	Why?
Activities of Daily Living	2	2006	2430	0.030	Why?
Schizophrenia	4	2006	6983	0.030	Why?
Promethazine	4	1975	29	0.030	Why?
Telemedicine	1	2010	3109	0.020	Why?
Hyperthyroidism	1	1994	292	0.020	Why?
Phenobarbital	3	1981	192	0.020	Why?
Leukoencephalopathy, Progressive Multifocal	1	1973	133	0.020	Why?
Peripheral Nervous System Diseases	1	1997	716	0.020	Why?
Risk Assessment	1	2013	24315	0.020	Why?
Untranslated Regions	1	2011	30	0.020	Why?
Risk Factors	2	2011	74944	0.020	Why?
Meta-Analysis as Topic	1	2016	1363	0.020	Why?
Neurotransmitter Agents	3	1980	663	0.020	Why?
Child	7	2011	80917	0.020	Why?
Age Factors	2	2006	18412	0.020	Why?
Research Design	1	2007	6211	0.020	Why?
Drug Administration Schedule	2	1997	4860	0.020	Why?
Glycerol	1	1971	274	0.020	Why?
Incidence	2	2006	21538	0.020	Why?
Mycetoma	1	1990	18	0.020	Why?
Muscle Contraction	1	1995	1209	0.020	Why?
Peripheral Nerves	1	1994	490	0.020	Why?
Prospective Studies	3	2007	54926	0.020	Why?
Foot	1	1994	576	0.020	Why?
Postoperative Complications	2	2009	15832	0.020	Why?
Myography	1	2010	111	0.020	Why?
Range of Motion, Articular	1	1996	1597	0.020	Why?
Behavior	3	1978	542	0.020	Why?
Age of Onset	2	2009	3347	0.020	Why?
Cognition Disorders	1	2002	3980	0.020	Why?
Transducers	1	2010	243	0.020	Why?
Meningitis	1	1990	219	0.020	Why?
Tomography Scanners, X-Ray Computed	1	2009	171	0.020	Why?
Brain Diseases	1	1977	1554	0.020	Why?
Internationality	1	2013	1008	0.020	Why?
United States	4	2011	73039	0.020	Why?
Denervation	2	1980	265	0.020	Why?
Animals	19	2003	169246	0.020	Why?
Echocardiography, Transesophageal	1	1993	1096	0.020	Why?
Myelitis, Transverse	1	1987	40	0.020	Why?
Video Recording	1	2012	976	0.020	Why?
Nervous System Diseases	1	1978	1662	0.020	Why?
Extremities	1	2012	870	0.020	Why?
Myelitis	1	1987	49	0.020	Why?
Rats	7	1978	23760	0.020	Why?
Cerebral Infarction	1	1971	969	0.020	Why?
Brain Ischemia	1	2000	3007	0.020	Why?
GABA Antagonists	2	1978	119	0.020	Why?
Neuropsychological Tests	2	2014	7140	0.020	Why?
Electric Impedance	1	2010	794	0.020	Why?
Parkinson Disease, Postencephalitic	2	1975	3	0.020	Why?
Autoantibodies	1	1994	2121	0.020	Why?
Diazepam	3	1975	214	0.020	Why?
Specialization	1	1970	779	0.020	Why?
Young Adult	4	2016	60066	0.020	Why?
Dominance, Cerebral	1	2006	623	0.010	Why?
Light	1	2010	1355	0.010	Why?
Acetylcholine	2	1978	629	0.010	Why?
Gene Frequency	1	2011	3623	0.010	Why?
Patient Satisfaction	1	1996	3488	0.010	Why?
Lymph Nodes	1	1995	3474	0.010	Why?
Home Care Services	1	2010	659	0.010	Why?
Chronic Disease	1	1998	9384	0.010	Why?
Exons	1	2009	2394	0.010	Why?
Drug Combinations	1	2009	2089	0.010	Why?
Electroencephalography	2	1995	6314	0.010	Why?
Electron Transport	1	2003	211	0.010	Why?
Neural Inhibition	2	1977	588	0.010	Why?
Nausea	2	1975	682	0.010	Why?
Pedigree	1	2010	4539	0.010	Why?
Placebos	2	1997	1667	0.010	Why?
Psychomotor Performance	2	2002	1892	0.010	Why?
Diabetes Mellitus, Type 1	2	1994	3447	0.010	Why?
Benzodiazepinones	1	1981	50	0.010	Why?
Pain	1	1996	5100	0.010	Why?
Clonazepam	1	1981	135	0.010	Why?
Cytomegalovirus Infections	1	1987	837	0.010	Why?
Single-Blind Method	1	2004	1587	0.010	Why?
DNA Mutational Analysis	1	2009	4120	0.010	Why?
Evoked Potentials, Somatosensory	1	2002	246	0.010	Why?
Receptors, Glutamate	1	2001	229	0.010	Why?
Conserved Sequence	1	2003	1162	0.010	Why?
Cross-Sectional Studies	1	2001	26379	0.010	Why?
Homovanillic Acid	1	1979	73	0.010	Why?
Hydroxyindoleacetic Acid	1	1979	94	0.010	Why?
Synaptic Transmission	2	1977	1177	0.010	Why?
Probenecid	1	1979	73	0.010	Why?
Scopolamine	2	1978	93	0.010	Why?
Perceptual Disorders	1	2001	199	0.010	Why?
Disease Models, Animal	2	1976	18349	0.010	Why?
Magnetic Resonance Imaging	2	2003	36743	0.010	Why?
Phenoxybenzamine	2	1975	53	0.010	Why?
Azores	1	1978	5	0.010	Why?
Benztropine	1	1977	17	0.010	Why?
Stimulation, Chemical	1	1978	305	0.010	Why?
Amino Acid Sequence	1	2010	13421	0.010	Why?
Education, Medical	1	1970	1742	0.010	Why?
Random Allocation	1	2002	2396	0.010	Why?
Magnetoencephalography	1	2002	641	0.010	Why?
Parasympathetic Nervous System	1	1978	144	0.010	Why?
Limbic System	1	1980	424	0.010	Why?
Synapses	2	1979	1765	0.010	Why?
Amphetamine	2	1975	222	0.010	Why?
Molecular Sequence Data	1	2010	17622	0.010	Why?
Carnitine	1	1978	253	0.010	Why?
Paresthesia	1	1997	160	0.010	Why?
Cohort Studies	2	2010	41754	0.010	Why?
Nerve Endings	1	1976	103	0.010	Why?
Child, Preschool	2	2010	42669	0.010	Why?
Sickness Impact Profile	1	1997	299	0.010	Why?
Genotype	1	2011	13045	0.010	Why?
Reaction Time	1	2002	2101	0.010	Why?
Anti-Bacterial Agents	1	1995	7477	0.010	Why?
Mice, Inbred Strains	2	1978	1765	0.010	Why?
Terminology as Topic	1	1983	1542	0.010	Why?
Dibenzazepines	1	1975	26	0.010	Why?
Amphetamines	1	1976	142	0.010	Why?
Methyltyrosines	1	1974	7	0.010	Why?
Haplorhini	1	1976	523	0.010	Why?
History, 20th Century	1	1983	2766	0.010	Why?
Electrophysiology	1	1978	1266	0.010	Why?
Clozapine	2	1975	509	0.010	Why?
Cyclic AMP	1	1979	1470	0.010	Why?
New England	1	1978	1058	0.010	Why?
Evolution, Molecular	1	2003	1896	0.010	Why?
Drug Evaluation, Preclinical	1	1980	1338	0.010	Why?
Growth Hormone	1	1977	573	0.010	Why?
Athetosis	1	1974	15	0.010	Why?
Reproducibility of Results	1	2012	20227	0.010	Why?
Handwriting	1	1974	26	0.010	Why?
Drug Interactions	2	1978	1419	0.010	Why?
Phenothiazines	1	1974	60	0.010	Why?
Hypertension	2	2009	8616	0.010	Why?
Art	1	1974	66	0.010	Why?
gamma-Globulins	1	1973	119	0.010	Why?
Posture	2	1975	957	0.010	Why?
Tomography, X-Ray Computed	2	1993	20760	0.010	Why?
Nerve Degeneration	1	1977	749	0.010	Why?
Electric Stimulation	1	1997	1741	0.010	Why?
Hydroxydopamines	3	1976	59	0.010	Why?
Locomotion	1	1974	388	0.010	Why?
Kidney Transplantation	1	1987	4262	0.010	Why?
Oxidative Stress	1	2003	3139	0.010	Why?
Vomiting	1	1975	655	0.010	Why?
Injections, Intravenous	1	1974	1377	0.010	Why?
Schizophrenic Psychology	1	1978	1649	0.010	Why?
Syndrome	1	1977	3272	0.010	Why?
Skin Tests	1	1973	639	0.010	Why?
Patient Compliance	1	2001	2697	0.010	Why?
Motor Cortex	1	1978	1013	0.010	Why?
Fresh Water	1	1990	83	0.010	Why?
Internship and Residency	1	1970	5953	0.010	Why?
Drug Synergism	1	1973	1760	0.010	Why?
Tyrosine	1	1973	1427	0.010	Why?
Pneumonia, Aspiration	1	1990	145	0.000	Why?
Autopsy	1	1973	1011	0.000	Why?
Mass Screening	1	2004	5458	0.000	Why?
Mice	7	1978	82029	0.000	Why?
Cerebral Arteries	1	1990	488	0.000	Why?
Infant	1	2010	36535	0.000	Why?
Catheterization	1	1973	1430	0.000	Why?
Brain Edema	1	1971	601	0.000	Why?
Sarcoidosis	1	1973	535	0.000	Why?
Genetic Predisposition to Disease	1	2009	18065	0.000	Why?
Dextroamphetamine	2	1978	132	0.000	Why?
Recurrence	1	1978	8509	0.000	Why?
Models, Biological	2	1979	9495	0.000	Why?
Drug Therapy, Combination	1	1975	6316	0.000	Why?
Cerebral Angiography	1	1990	1264	0.000	Why?
Neural Pathways	1	1975	3117	0.000	Why?
Body Weight	1	1974	4627	0.000	Why?
Drug Hypersensitivity	1	1971	923	0.000	Why?
Seizures	1	1975	2998	0.000	Why?
Brain Mapping	1	1975	6685	0.000	Why?
Neurons	1	1979	9514	0.000	Why?
Depression	1	1979	8230	0.000	Why?
Scopolamine Derivatives	1	1978	24	0.000	Why?
Depression, Chemical	1	1976	186	0.000	Why?
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide	1	1975	1	0.000	Why?
Biogenic Amines	1	1975	53	0.000	Why?
Pentobarbital	1	1975	153	0.000	Why?
Isomerism	1	1975	198	0.000	Why?
Antidepressive Agents, Tricyclic	1	1976	430	0.000	Why?
Brain Chemistry	1	1975	958	0.000	Why?
Structure-Activity Relationship	1	1975	3055	0.000	Why?

Tarsy's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (440)

Explore

Co-Authors (28)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors